Zusammenfassung
Unmittelbar nach körperlicher Aktivität ist abhängig von Dauer und Intensität der Belastung eine lokale muskelzelluläre und systemische Entzündungsreaktion nachweisbar. Pathophysiologisch sind u. a. eine zelluläre Aktivierung von Lymphozyten und Makrophagen, eine vermehrte Freisetzung von Zytokinen in der Muskulatur sowie die Induktion einer hepatischen Akute-Phase-Reaktion anzuführen. Demgegenüber reduziert regelmäßige körperliche Aktivität eine überschießende Akutreaktion und vermindert chronisch die Spiegel inflammatorischer Marker. Es ist davon auszugehen, dass eine sportinduzierte Verringerung der Entzündungskonstellation die Morbidität und Mortalität vor allem bei chronisch-degenerativen Erkrankungen positiv beeinflusst. Ob dies durch eine Verringerung der Entzündungskonstellation per se oder indirekt durch die Verminderung der proinflammatorischen Risikokonstellation bewirkt wird, kann derzeit noch nicht abschließend beurteilt werden.
Abstract
Immediately after physical activity a cellular and systemic inflammation can be detected which depends on duration and intensity of the impact. In pathophysiological terms this is characterized by an activation of lymphocytes and macrophages, an increased release of cytokines into muscular tissue as well as the induction of a hepatic acute phase reaction. In contrast, regular physical activity can reduce both, an excessive acute reaction and a chronic level of inflammatory markers. It can be assumed that a sports-induced reduction of the inflammatory constellation reduces mortality and morbidity, in particular in chronic degenerative diseases. It's not clear yet, whether this is achieved directly by a reduced inflammation or indirectly via an attenuation of pro-inflammatory factors.
Schlüsselwörter
körperliche Aktivität - Myokine - metabolisches Syndrom - proinflammatorische Zytokine
Key words
physical activity - myokines - metabolic syndrome - pro-inflammatory cytokine
Literatur
1
Löllgen H.
Primärprävention kardialer Erkrankungen: Stellenwert der körperlichen Aktivität.
Deutsch Ärzteblatt.
2003;
100
A-987-A-996
2
Ernst N D, Cleeman J I.
National cholesterol education program keeps a priority on lifestyle modification to decrease cardiovascular disease risk.
Curr Opin Lipidol.
2002;
13
69-73
3
Pate R R, Pratt M, Blair S N. et al .
Physical activity and public health. A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine.
JAMA.
1995;
273
402-407
4
Nelson M E, Rejeski W J, Blair S N. et al .
Physical activity and public health in older adults: recommendation from the American College of Sports Medicine and the American Heart Association.
Med Sci Sports Exerc.
2007;
39
1435-1445
5
American College of Sports Medicine Position Stand .
The recommended quantity and quality of exercise for developing and maintaining cardiorespiratory and muscular fitness, and flexibility in healthy adults.
Med Sci Sports Exerc.
1998;
30
975-991
6
Mensink G B.
[Physical activity].
Gesundheitswesen.
1999;
61, Spec No
S126-S131
7
Häussinger D, Lang F, Gerok W.
Regulation of cell function by the cellular hydration state.
Am J Physiol.
1994;
267
E343-E355
8
Krauss R M.
The Tangled Web of Coronary Risk Factors.
Am J Med.
1991;
90
S36-S41
9
Halle M, Berg A, Keul J.
Übergewicht als Risikofaktor kardiovaskulärer Erkrankungen und die mögliche Bedeutung als Promotor einer gesteigerten Entzündungsreaktion.
DMW.
1999;
30
905-909
10
Ravussin E, Smith S R.
Increased fat intake, impaired fat oxidation, and failure of fat cell proliferation result in ectopic fat storage, insulin resistance, and type 2 diabetes mellitus.
Ann N Y Acad Sci.
2002;
967
363-378
11
Berg A, Frey I, Baumstark M W, Halle M, Keul J.
Physical activity and lipoprotein lipid disorders.
Sports Med.
1994;
17
6-21
12
Berg A, Halle M, Franz I, Keul J.
Physical activity and lipoprotein metabolism: Epidemiological evidence and clinical trials.
Eur J Med Res.
1997;
2
259-264
13
Hurley B F, Nemeth P M, Martin W H, Hagberg J M, Dalsky G P, Holloszy J O.
Muscle triglyceride utilisation during exercise: effect of training.
J Appl Physiol.
1986;
60
562-567
14
Jansson E, Kaijser L.
Substrate utilization and enzymes in skeletal muscle of extremely endurance-trained men.
J Appl Physiol.
1987;
62
999-1005
15
Romijn J A, Coyle E F, Sidossis L S, Rosenblatt J, Wolfe R R.
Substrate metabolism during different exercise intensities in endurance-trained women.
J Appl Physiol.
2000;
88
1707-1714
16
Berg A.
Körperliche Aktivtät und Übergewicht - was können Sport und Bewegung leisten.
Akt Ernähr Med.
2003;
28
292-299
17
Konig D, Neubauer O, Nics L. et al .
Biomarkers of exercise-induced myocardial stress in relation to inflammatory and oxidative stress.
Exerc Immunol Rev.
2007;
13
15-36
18
Bruunsgaard H, Galbo H, Halkjaer-Kristensen J, Johansen T L, MacLean D A, Pedersen B K.
Exercise-induced increase in serum interleukin-6 in humans is related to muscle damage.
J Physiol (Lond).
1997;
499
833-841
19
Peake J, Nosaka K, Suzuki K.
Characterization of inflammatory responses to eccentric exercise in humans.
Exerc Immunol Rev.
2005;
11
64-85
20
Pedersen B K, Fischer C P.
Beneficial health effects of exercise-the role of IL-6 as a myokine.
Trends Pharmacol Sci.
2007;
28
152-156
21
Glund S, Krook A.
Role of interleukin-6 signalling in glucose and lipid metabolism.
Acta Physiol (Oxf).
2008;
192
37-48
22
Pedersen B K, Ostrowski K, Rohde T, Bruunsgaard H.
The cytokine response to strenuous exercise.
Can J Physiol Pharmacol.
1998;
76
505-511
23
Weight L M, Alexander D, Jacobs P.
Strenuous exercise: analogous to the acute-phase response?.
Clin Sci (Colch).
1991;
81
677-683
24
Wilund K R.
Is the anti-inflammatory effect of regular exercise responsible for reduced cardiovascular disease?.
Clin Sci (Lond).
2007;
112
543-555
25
Isomaa B, Almgren P, Tuomi T. et al .
Cardiovascular morbidity and mortality associated with the metabolic syndrome.
Diabetes Care.
2001;
24
683-689
26
Grundy S M.
Inflammation, hypertension, and the metabolic syndrome.
JAMA.
2003;
290
3000-3002
27
Ridker P M, Wilson P W, Grundy S M.
Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk?.
Circulation.
2004;
109
2818-2825
28
Das U N.
Metabolic syndrome X: an inflammatory condition?.
Curr Hypertens Rep.
2004;
6
66-73
29
Pearson T A, Mensah G A, Alexander R W. et al .
Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association.
Circulation.
2003;
107
499-511
30
Willerson J T, Ridker P M.
Inflammation as a cardiovascular risk factor.
Circulation.
2004;
109
II 2-10
31
Libby P, Ridker P M.
Novel inflammatory markers of coronary risk: theory versus practice.
Circulation.
1999;
100
1148-1150
32
Ridker P M, Rifai N, Stampfer M J, Hennekens C H.
Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men.
Circulation.
2000;
101
1767-1772
33
Libby P, Theroux P.
Pathophysiology of coronary artery disease.
Circulation.
2005;
111
3481-3488
34
Abramson J L, Vaccarino V.
Relationship between physical activity and inflammation among apparently healthy middle-aged and older US adults.
Arch Intern Med.
2002;
162
1286-1292
35
Ford E S.
Does exercise reduce inflammation? Physical activity and C-reactive protein among U.S. adults.
Epidemiology.
2002;
13
561-568
36
Wannamethee S G, Lowe G D, Whincup P H, Rumley A, Walker M, Lennon L.
Physical activity and hemostatic and inflammatory variables in elderly men.
Circulation.
2002;
105
1785-1790
37
Milani R V, Lavie C J, Mehra M R.
Reduction in C-reactive protein through cardiac rehabilitation and exercise training.
J Am Coll Cardiol.
2004;
43
1056-1061
38
Berg Jr A, Deibert P, Berg A, König D, Dickhuth H H.
Current views on the importance of physical activity.
MMW Fortschr Med.
2004;
146
27-30
39
Gielen S, Adams V, Mobius-Winkler S. et al .
Anti-inflammatory effects of exercise training in the skeletal muscle of patients with chronic heart failure.
J Am Coll Cardiol.
2003;
42
861-868
40
Plaisance E P, Grandjean P W.
Physical activity and high-sensitivity C-reactive protein.
Sports Med.
2006;
36
443-458
41
Schumacher A, Peersen K, Sommervoll L, Seljeflot I, Arnesen H, Otterstad J E.
Physical performance is associated with markers of vascular inflammation in patients with coronary heart disease.
Eur J Cardiovasc Prev Rehabil.
2006;
13
356-362
42
Laaksonen D E, Lakka H M, Salonen J T, Niskanen L K, Rauramaa R, Lakka T A.
Low levels of leisure-time physical activity and cardiorespiratory fitness predict development of the metabolic syndrome.
Diabetes Care.
2002;
25
1612-1618
43
Tanasescu M, Leitzmann M F, Rimm E B, Hu F B.
Physical activity in relation to cardiovascular disease and total mortality among men with type 2 diabetes.
Circulation.
2003;
107
2435-2439
44
Galassi A, Reynolds K, He J.
Metabolic syndrome and risk of cardiovascular disease: a meta-analysis.
Am J Med.
2006;
119
812-819
PD Dr. Daniel König
Abteilung Präventive und Rehabilitative Sportmedizin
Hugstetter Straße 49
79095 Freiburg
Telefon: 0761/2707495
eMail: daniel.koenig@uniklinik-freiburg.de